Sign in
4

Changes in Ownership

Humacyte, Inc. Filed Acc 0001628280-25-052715

Options or other derivatives

  • President, CEO and Director acquired 311,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Niklason Laura E · President, CEO and Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-11-16 Grant or award : show line 1 in the form Stock Options (right to buy) +311,100 311,100 D
Loading xslF345X05/wk-form4_1763419703.xml…